• Sign up to our Free Newsletter
  • Contact Us
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Month: March 2019

Pharma & Human Health

Viome and Helomics Partner to Identify Personalized Treatment for Ovarian Cancer Patients

March 27, 2019 Microbiome Times

Viome, a company transforming health through personalized nutrition based on individual biology, announced it will collaborate with precision health leader, Helomics, to study the link between the gut microbiome and ovarian cancer. The teams will […]

Pharma & Human Health

New Study Identifies Potential Treatment For Higher Rate Of Preterm Birth Among African American Women

March 27, 2019 Microbiome Times

It may be possible to lower the high risk of preterm birth among African American women with certain immune and bacterial factors in the microbiome of the cervix and vagina that appear to modulate this […]

Pharma & Human Health

Clinical Study Results Demonstrate Benefits of High-Potency, Multi-Strain Probiotic Formulations

March 25, 2019 Microbiome Times

Results from a clinical trial performed by Taverniti and colleagues from the University of Milan (IT) suggest that ingesting higher doses of multispecies probiotic formulations may permit higher, earlier and longer recovery of probiotics in […]

Editor's Choice

Intellectual Property Considerations for the Microbiome: Personalized Strategies for a Diverse Space

March 25, 2019 Scott Siera

While the microbiome space is often compared to the traditional pharmaceutical and biotechnology industries, the scientific, regulatory, and marketing strategies for microbiome products and platforms often differ from those centered on a single small molecule or large […]

Pharma & Human Health

MTIG Position Statement on FMT Regulations

March 25, 2019 Microbiome Times

The Microbiome Therapeutics Innovation Group (MTIG) announced the publication of its Position Statement on Fecal Microbiota Transplantation (FMT) treatment. The statement supports the FDA Draft Guidance providing for patient access to FMT treatment through clinical […]

Pharma & Human Health

Enterome Announces Research Collaboration with Dana-Farber Cancer Institute Focused on New Microbiome-derived Cancer Immunotherapy

March 22, 2019 Microbiome Times

ENTEROME SA, a clinical-stage biopharmaceutical company leveraging its unique knowledge of the key functional and molecular interactions between the gut microbiome and the human body to develop targeted therapeutics, has entered into a research and […]

Finance

Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca

March 11, 2019 Microbiome Times

Seres Therapeutics, Inc. (Nasdaq: MCRB) today announced a three-year research collaboration with AstraZeneca. The collaboration will focus on advancing mechanistic understanding of the microbiome in augmenting the efficacy of cancer immunotherapy, including potential synergy with […]

Finance

SNIPR BIOME raises $50 million Series A financing to advance CRISPR-based microbiome drugs to human clinical trials

March 11, 2019 Microbiome Times

SNIPR BIOME, a leading CRISPR and microbiome private biotech company incorporated in Copenhagen, Denmark, today announced a $50 million series A financing led by existing investor Lundbeckfonden Emerge (Copenhagen) and LSP (Amsterdam), together with North-East […]

Finance

L’Oréal Announces Partnership With uBiome To Advance New Research Into The Skin Microbiome

March 11, 2019 Microbiome Times

L’Oréal announced a partnership between its Technology Incubator and Silicon Valley-based uBiome, the leader in microbial genomics, to continue its longtime research into skin microbiome—the trillions of bacteria that live on, and provide an important […]

Pharma & Human Health

On Intended Use – the Alpha & Ωmega of Defining Regulatory Status

March 5, 2019 Dr. Magali Cordaillat-Simmons (PhD) and Alice Rouanet

In your life as a Regulatory Affairs professional, it will invariably dawn on you at some point that concepts which are at the heart of your daily responsibilities (and which eventually begin to seem obvious, […]

Editor's Choice

Health for Life Capital II™, World Leading Microbiome-focused Fund Announces its First Close

March 5, 2019 Microbiome Times

Seventure Partners, one of Europe’s leaders in financing innovation and a world-leader in life science microbiome investment, announces it has completed the first closing of its second dedicated fund focused on the microbiome, and health, […]

Posts navigation

1 2 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • New standards in sensitivity and accuracy for microbiome research
    September 20, 2023
  • Integrating Microbiome and Dietary Data: Microbiome Data Congress 2023
    August 22, 2023
  • Distinguishing Strains in Microbiome Samples: Considerations and Challenges
    July 19, 2023
  • Proven Complementary Effect of Probiotic Yeast and Bacteria
    June 21, 2023
  • Microbiome drug development: Analysis of the historical pipeline reveals promising areas and bottlenecks
    May 25, 2023
sign up

Sign up to the Microbiome Times newsletter